Conor McNamara
Stock Analyst at RBC Capital
(1.12)
# 3,798
Out of 5,182 analysts
128
Total ratings
30.1%
Success rate
-13.81%
Average return
Main Sectors:
Stocks Rated by Conor McNamara
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TECH Bio-Techne | Upgrades: Outperform | $61 → $73 | $55.11 | +32.46% | 11 | Sep 3, 2025 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Outperform | $7 → $5 | $3.68 | +35.87% | 7 | Aug 12, 2025 | |
| NTRA Natera | Maintains: Outperform | $251 → $255 | $204.39 | +24.76% | 2 | Aug 8, 2025 | |
| OABI OmniAb | Maintains: Outperform | $4 → $3 | $1.44 | +108.33% | 4 | Aug 7, 2025 | |
| AVTR Avantor | Maintains: Outperform | $20 → $17 | $7.97 | +113.30% | 9 | Aug 4, 2025 | |
| ILMN Illumina | Maintains: Outperform | $118 → $126 | $128.52 | -1.96% | 16 | Aug 1, 2025 | |
| BIO Bio-Rad Laboratories | Maintains: Outperform | $387 → $409 | $287.29 | +42.36% | 14 | Aug 1, 2025 | |
| BIO.B Bio-Rad Laboratories | Maintains: Outperform | $387 → $409 | $291.46 | +40.33% | 14 | Aug 1, 2025 | |
| RGEN Repligen | Maintains: Outperform | $193 → $204 | $118.29 | +72.46% | 12 | Jul 30, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Outperform | $651 → $637 | $468.04 | +36.10% | 14 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $250 | $180.62 | +38.41% | 10 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $64 → $61 | $12.29 | +396.34% | 11 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $8 → $7 | $4.86 | +44.03% | 4 | Aug 7, 2024 |
Bio-Techne
Sep 3, 2025
Upgrades: Outperform
Price Target: $61 → $73
Current: $55.11
Upside: +32.46%
Maravai LifeSciences Holdings
Aug 12, 2025
Maintains: Outperform
Price Target: $7 → $5
Current: $3.68
Upside: +35.87%
Natera
Aug 8, 2025
Maintains: Outperform
Price Target: $251 → $255
Current: $204.39
Upside: +24.76%
OmniAb
Aug 7, 2025
Maintains: Outperform
Price Target: $4 → $3
Current: $1.44
Upside: +108.33%
Avantor
Aug 4, 2025
Maintains: Outperform
Price Target: $20 → $17
Current: $7.97
Upside: +113.30%
Illumina
Aug 1, 2025
Maintains: Outperform
Price Target: $118 → $126
Current: $128.52
Upside: -1.96%
Bio-Rad Laboratories
Aug 1, 2025
Maintains: Outperform
Price Target: $387 → $409
Current: $287.29
Upside: +42.36%
Bio-Rad Laboratories
Aug 1, 2025
Maintains: Outperform
Price Target: $387 → $409
Current: $291.46
Upside: +40.33%
Repligen
Jul 30, 2025
Maintains: Outperform
Price Target: $193 → $204
Current: $118.29
Upside: +72.46%
Thermo Fisher Scientific
Apr 24, 2025
Maintains: Outperform
Price Target: $651 → $637
Current: $468.04
Upside: +36.10%
Apr 23, 2025
Reiterates: Outperform
Price Target: $250
Current: $180.62
Upside: +38.41%
Feb 13, 2025
Maintains: Outperform
Price Target: $64 → $61
Current: $12.29
Upside: +396.34%
Aug 7, 2024
Maintains: Outperform
Price Target: $8 → $7
Current: $4.86
Upside: +44.03%